Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Emulgels are effective for delivering skin medications due to their unique gel-emulsion mix.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Topical eflornithine effectively reduces facial hair in women and improves quality of life.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Emollients can make fabrics more flammable, so take safety precautions.

Gefitinib can cause hair loss without scarring.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Flutamide treatment showed no significant changes in mice vaginal mucosa.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Emulgels effectively deliver hydrophobic drugs for skin conditions like acne and psoriasis.

Flumethasone causes wool shedding in Merino wethers, with recovery in about 60 days.

Topical eflornithine effectively reduces unwanted facial hair in women with hirsutism for at least 6 months.

Using Eflornithine cream with laser treatments improves facial hair removal.

New method accurately measures finasteride in tablets.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Fermented mushroom extract reduces intestinal inflammation in mice.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The new fluoroquinolone effectively fights certain bacteria.

Reducing Flightless I protein improves wound healing by activating skin stem cells.